DOK2
Basic information
Region (hg38): 8:21908873-21913690
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DOK2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 36 | 38 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 36 | 0 | 2 |
Variants in DOK2
This is a list of pathogenic ClinVar variants found in the DOK2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-21909367-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
8-21909370-A-C | Benign (Jan 18, 2019) | |||
8-21909375-G-C | not specified | Uncertain significance (Aug 02, 2021) | ||
8-21909382-C-A | not specified | Uncertain significance (Oct 28, 2023) | ||
8-21909435-G-A | not specified | Uncertain significance (Apr 04, 2024) | ||
8-21909444-C-T | not specified | Uncertain significance (Sep 14, 2023) | ||
8-21909484-G-A | not specified | Uncertain significance (Apr 25, 2022) | ||
8-21909505-C-T | not specified | Uncertain significance (Jan 29, 2024) | ||
8-21909510-T-C | not specified | Uncertain significance (Dec 19, 2022) | ||
8-21909516-T-C | not specified | Uncertain significance (Feb 05, 2024) | ||
8-21909534-G-C | not specified | Uncertain significance (Aug 10, 2021) | ||
8-21909583-G-C | not specified | Uncertain significance (May 25, 2022) | ||
8-21909641-G-C | not specified | Uncertain significance (Sep 07, 2022) | ||
8-21909682-G-T | not specified | Uncertain significance (Apr 22, 2022) | ||
8-21909714-G-A | not specified | Uncertain significance (Jan 24, 2024) | ||
8-21909720-G-A | not specified | Uncertain significance (Jan 23, 2023) | ||
8-21909726-T-C | not specified | Uncertain significance (Dec 21, 2022) | ||
8-21909732-C-T | not specified | Uncertain significance (Dec 05, 2022) | ||
8-21909733-G-A | not specified | Uncertain significance (Nov 17, 2022) | ||
8-21909744-C-A | not specified | Uncertain significance (Nov 17, 2022) | ||
8-21909757-G-A | not specified | Uncertain significance (Jun 29, 2023) | ||
8-21909762-G-A | not specified | Uncertain significance (Jul 30, 2023) | ||
8-21909768-G-A | not specified | Uncertain significance (Oct 02, 2023) | ||
8-21909772-T-C | not specified | Likely benign (Apr 15, 2024) | ||
8-21909786-G-A | not specified | Uncertain significance (Jan 17, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DOK2 | protein_coding | protein_coding | ENST00000276420 | 5 | 4988 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000121 | 0.836 | 125506 | 2 | 232 | 125740 | 0.000931 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.864 | 306 | 266 | 1.15 | 0.0000183 | 2573 |
Missense in Polyphen | 111 | 90.853 | 1.2218 | 856 | ||
Synonymous | -0.909 | 124 | 112 | 1.11 | 0.00000757 | 875 |
Loss of Function | 1.36 | 10 | 15.8 | 0.631 | 8.25e-7 | 172 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00107 | 0.00106 |
Ashkenazi Jewish | 0.0159 | 0.0136 |
East Asian | 0.000331 | 0.000326 |
Finnish | 0.000108 | 0.0000924 |
European (Non-Finnish) | 0.000441 | 0.000413 |
Middle Eastern | 0.000331 | 0.000326 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000882 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: DOK proteins are enzymatically inert adaptor or scaffolding proteins. They provide a docking platform for the assembly of multimolecular signaling complexes. DOK2 may modulate the cellular proliferation induced by IL-4, as well as IL-2 and IL-3. May be involved in modulating Bcr-Abl signaling. Attenuates EGF-stimulated MAP kinase activation (By similarity). {ECO:0000250}.;
- Pathway
- Angiogenesis overview;Rac1-Pak1-p38-MMP-2 pathway;IL-4 Signaling Pathway;EGF-EGFR Signaling Pathway;Developmental Biology;TCR;Fibroblast growth factor-1;EGFR1;Tie2 Signaling;Cell surface interactions at the vascular wall;Hemostasis;IL2-mediated signaling events;Angiopoietin receptor Tie2-mediated signaling;IL4;RET signaling;Axon guidance;IL4-mediated signaling events
(Consensus)
Recessive Scores
- pRec
- 0.154
Intolerance Scores
- loftool
- 0.466
- rvis_EVS
- -0.42
- rvis_percentile_EVS
- 25.73
Haploinsufficiency Scores
- pHI
- 0.0796
- hipred
- N
- hipred_score
- 0.314
- ghis
- 0.523
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.794
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dok2
- Phenotype
- endocrine/exocrine gland phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype; respiratory system phenotype; neoplasm;
Gene ontology
- Biological process
- signal transduction;cell surface receptor signaling pathway;transmembrane receptor protein tyrosine kinase signaling pathway;Ras protein signal transduction;axon guidance;leukocyte migration
- Cellular component
- cytosol
- Molecular function
- transmembrane receptor protein tyrosine kinase adaptor activity;protein binding